Advances in the structural biology, design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia
Author:
Publisher
Elsevier BV
Subject
Molecular Biology,Biochemistry,Biophysics,Analytical Chemistry
Reference75 articles.
1. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia;Ren;Nat. Rev., Cancer,2005
2. Philadelphia chromosome-positive acute lymphoblastic leukemia—current concepts and future perspectives;Faderl;Rev. Clin. Exp. Haematol.,2002
3. Sustained durability of responses plus high rates of cytogenetic responses result in long-term benefit for newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP) treated with imatinib (IM) therapy: update from the IRIS study;Guilhot;Blood,2004
4. Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3;Holyoake;Blood,2001
5. Bcr-Abl kinase mutations and drug resistance to imatinib (STI571) in chronic myelogenous leukemia;Cowan-Jacob;Mini Rev. Med. Chem.,2004
Cited by 148 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Harmonizing the craft of crafting clinically endorsed small-molecule BCR-ABL tyrosine kinase inhibitors for the treatment of hematological malignancies;European Journal of Pharmaceutical Sciences;2024-02
2. BCR‐ABL Inhibitors;Molecules Engineered Against Oncogenic Proteins and Cancer;2023-09-08
3. Anticancer drugs acting on signaling pathways, part 1: Tyrosine kinase inhibitors;Medicinal Chemistry of Anticancer Drugs;2023
4. Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia;Frontiers in Oncology;2022-09-23
5. Are off-target effects of imatinib the key to improving beta-cell function in diabetes?;Upsala Journal of Medical Sciences;2022-09-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3